Rigel Pharmaceuticals (RIGL) Debt Ratio (2019 - 2026)

Rigel Pharmaceuticals has reported Debt Ratio for 8 years, with the latest figure at 0.15 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio fell 56.39% year-over-year to 0.15; the trailing twelve-month figure through Mar 2026 stood at 0.15 (down 56.39% YoY), and the FY2025 full-year result was 0.1, down 72.02% from the prior year.
• Debt Ratio for Q1 2026 stood at 0.15, up from 0.1 in the prior quarter.
• The five-year high for Debt Ratio was 0.52 in Q3 2023, with the low at 0.1 in Q4 2025.
• Average Debt Ratio over 5 years is 0.35, with a median of 0.34 recorded in 2022.
• Year-over-year, Debt Ratio soared 220.19% in 2022 and tumbled 72.02% in 2025.
• Tracing RIGL's Debt Ratio over 5 years: stood at 0.29 in 2022, then jumped by 73.07% to 0.51 in 2023, then dropped by 28.42% to 0.36 in 2024, then plunged by 72.02% to 0.1 in 2025, then surged by 45.43% to 0.15 in 2026.
• The last three Debt Ratio figures came in at 0.15 (Q1 2026), 0.1 (Q4 2025), and 0.25 (Q3 2025), per Business Quant data.

Peer Comparison